1990
DOI: 10.1099/0022-1317-71-2-397
|View full text |Cite
|
Sign up to set email alerts
|

Reactivation of latent infection and induction of recurrent herpetic eye disease in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
100
1

Year Published

1990
1990
2019
2019

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 112 publications
(107 citation statements)
references
References 32 publications
6
100
1
Order By: Relevance
“…High incidences of reactivation of latent virus, shedding of virus in tears and recurrent herpetic eye disease can be induced in mice that survive with undamaged eyes after infection of the cornea with herpes simplex virus type 1 (HSV-1) (Shimeld et al, 1990). The incidence of such undamaged eyes can be greatly increased by passive immunization with serum containing antiviral antibodies before inoculation with virus (Shimeld et al, 1989).…”
Section: Introductionmentioning
confidence: 99%
“…High incidences of reactivation of latent virus, shedding of virus in tears and recurrent herpetic eye disease can be induced in mice that survive with undamaged eyes after infection of the cornea with herpes simplex virus type 1 (HSV-1) (Shimeld et al, 1990). The incidence of such undamaged eyes can be greatly increased by passive immunization with serum containing antiviral antibodies before inoculation with virus (Shimeld et al, 1989).…”
Section: Introductionmentioning
confidence: 99%
“…Other reports suggest that testing the mouse eye for infectious virus during post inoculation days ranging from 23 to 113 resulted in detection at a very low percentage. The rate of shedding was less than once per 100 days (Shimeld et al, 1990;Tullo et al, 1982;Willey et al, 1984). In most cases, only one eye shed infectious HSV-1 once on many continuous days of swabbing.…”
Section: Discussionmentioning
confidence: 98%
“…However, sometimes, episodes of herpetic ophthalmic disease result in the involvement of the deeper corneal tissue leading to corneal scarring with consequent reduction in visual acuity. Additionally, delay in the treatment of HSV-1 ophthalmic disease can lead to a more significant corneal scar, and topical steroid treatment in unsuspected active herpes ophthalmic can lead to corneal melting 3,4,6,10,11,15 .…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, we had previously optimized a murine model of HSV-1 ophthalmic disease, in which BALB/c mouse corneas were inoculated without trauma and with HSV-1 strain obtained from a patient with severe herpetic disease, to mimic the infection in humans 4,5,10,11,15 .…”
Section: Introductionmentioning
confidence: 99%